Capricor Therapeutics (CAPR) Research & Development (2010 - 2026)
Capricor Therapeutics (CAPR) posted Research & Development of $28.87 million for Q2 2026, up 30.9% from $22.05 million a year earlier and up 5.4% from the prior quarter.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Capricor Therapeutics was $99.78 million, up 48.2% year-over-year; for FY2025, it was $84.45 million, up 69.0% from FY2024.
- Annual Research & Development has increased for six consecutive years, with a five-year compound annual growth rate of 58.3% (FY2020 to FY2025).
- In prior years, Capricor Therapeutics' Research & Development was $49.97 million in FY2024 (+37.1%), $36.45 million in FY2023 (+67.1%), $21.82 million in FY2022 (+60.4%) and $13.6 million in FY2021 (+60.0%).
- The Q2 2026 figure stands as the highest quarterly Research & Development in data going back to Q2 2010.
- On a year-over-year basis, Research & Development has increased in each of the last 19 quarters, with growth averaging 52.3% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2022, with growth of 119.0%; the weakest was Q3 2021, with a decline of 4.4%.
- According to Business Quant data, Research & Development for the three prior quarters was $27.38 million (Q1 2026), $23.13 million (Q4 2025) and $20.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.98 Bn | 1,134.57 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 643.66 Bn | 563.53 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 500.95 Bn | 474.06 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 358.08 Bn | 312.45 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 301.84 Bn | 265.83 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.42 Bn | 196.81 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Capricor Therapeutics | 358.27 Mn | -574.97 Mn | - | 28.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.87 Mn |
| Mar 31, 2026 | 27.38 Mn |
| Dec 31, 2025 | 23.13 Mn |
| Sep 30, 2025 | 20.40 Mn |
| Jun 30, 2025 | 22.05 Mn |
| Mar 31, 2025 | 18.92 Mn |
| Dec 31, 2024 | 14.55 Mn |
| Sep 30, 2024 | 11.81 Mn |
| Jun 30, 2024 | 12.50 Mn |
| Mar 31, 2024 | 11.10 Mn |
| Dec 31, 2023 | 9.94 Mn |
| Sep 30, 2023 | 10.03 Mn |
| Jun 30, 2023 | 8.82 Mn |
| Mar 31, 2023 | 7.70 Mn |
| Dec 31, 2022 | 6.22 Mn |
| Sep 30, 2022 | 5.50 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 5.12 Mn |
| Dec 31, 2021 | 4.29 Mn |
| Sep 30, 2021 | 2.51 Mn |
API Access
Capricor Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CAPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CAPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CAPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();